SIGLEC10
Reactivity: Human
FACS
Host: Mouse
Monoclonal
5G6
FITC
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1.0 mg/mL
Kivi, Elima, Aalto, Nymalm, Auvinen, Koivunen, Otto, Crocker, Salminen, Salmi, Jalkanen: "Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate." in: Blood, Vol. 114, Issue 26, pp. 5385-92, (2009) (PubMed).
Nguyen, Hurtado-Ziola, Gagneux, Varki: "Loss of Siglec expression on T lymphocytes during human evolution." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 20, pp. 7765-70, (2006) (PubMed).
Munday, Kerr, Ni, Cornish, Zhang, Nicoll, Floyd, Mattei, Moore, Liu, Crocker: "Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor." in: The Biochemical journal, Vol. 355, Issue Pt 2, pp. 489-97, (2001) (PubMed).